Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018.

作者: Louisa Degenhardt , Phillip Hungerford , Suzanne Nielsen , Raimondo Bruno , Briony Larance

DOI: 10.1001/JAMANETWORKOPEN.2021.3059

关键词:

摘要: Importance: Despite concern about harms related to long-term prescribed opioid use among individuals with chronic noncancer pain (CNCP), no study has examined whether the same patients engage in a risky pattern of consistently for long term. Objective: To examine prevalence, incidence, persistence, and cessation range behaviors, indicators extramedical use, harm who are opioids. Design, Setting, Participants: This 5-year prospective cohort communities across Australia included 1514 adults were opioids CNCP. Data collection took place from August 2012 December 2018, data analysis February November 2020. Exposure: Prescription use. Main Outcomes Measures: High-dose (≥200 oral morphine equivalent [OME] mg/d); requesting an increase dose; early prescription renewal; tampering medication; diversion medication others; International Statistical Classification Diseases Related Health Problems, Tenth Revision dependence. Cessation was also assessed. Results: Of participants, 672 (44.39%) men, mean (SD) age 58 (19) years, 737 (48.68%) unemployed. At each annual interview, approximately 1 8 people (10.98% [95% CI, 10.33%-11.63%] 14.73% 13.98%-15.48%] at any given interview) taking more than 200 OME mg/d; comparatively had requested increased dosage previous 3 months (8.46% 7.89%-9.03%] 23.77% 22.82%-24.73%]); fewer asked renewal (4.61% 4.19%-5.03%] 13.97% 13.24%-14.70%]). In between 3.06% (95% 2.72%-3.40%) 7.86% 7.31%-8.41%) respondents reported 0.47% 0.33%-0.60%) 1.39% 1.16%-1.62%) others. Between 8.28% 7.71%-8.84%) 13.06% 12.35%-13.77%) met criteria dependence interview. Opioid interviews, year (9.15% 8.55%-9.74%]) 5 (20.02% [19.14%-20.89%]). There considerable incidence all behaviors interview next: most engaged these only did so For pharmaceutical dependence, 55.26% 53.81%-56.71%) 64.44% 62.87%-66.00%) cases not meet following interview. Conclusions Relevance: These findings suggest fluidity reinforces need reassessment effectiveness safety over time.

参考文章(29)
Suzanne Nielsen, Louisa Degenhardt, Bianca Hoban, Natasa Gisev, None, Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research National Drug and Alcohol Research Centre. ,(2014)
Briony Larance, Louisa Degenhardt, Nick Lintzeris, Adam Winstock, Richard Mattick, None, Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours Drug and Alcohol Review. ,vol. 30, pp. 236- 245 ,(2011) , 10.1111/J.1465-3362.2010.00283.X
Douglas Bates, Martin Mächler, Ben Bolker, Steve Walker, Fitting Linear Mixed-Effects Models Using lme4 Journal of Statistical Software. ,vol. 67, pp. 1- 48 ,(2015) , 10.18637/JSS.V067.I01
Roger Chou, Judith A. Turner, Emily B. Devine, Ryan N. Hansen, Sean D. Sullivan, Ian Blazina, Tracy Dana, Christina Bougatsos, Richard A. Deyo, The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop Annals of Internal Medicine. ,vol. 162, pp. 276- 286 ,(2015) , 10.7326/M14-2559
Kevin E. Vowles, Mindy L. McEntee, Peter Siyahhan Julnes, Tessa Frohe, John P. Ney, David N. van der Goes, Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. ,vol. 156, pp. 569- 576 ,(2015) , 10.1097/01.J.PAIN.0000460357.01998.F1
Gabrielle Campbell, Suzanne Nielsen, Raimondo Bruno, Nicholas Lintzeris, Milton Cohen, Wayne Hall, Briony Larance, Richard P Mattick, Louisa Degenhardt, None, The Pain and Opioids in Treatment study: Characteristics of a cohort using opioids to manage chronic non-cancer pain Pain. ,vol. 156, pp. 231- 242 ,(2015) , 10.1097/01.J.PAIN.0000460303.63948.8E
Gabrielle Campbell, Richard Mattick, Raimondo Bruno, Briony Larance, Suzanne Nielsen, Milton Cohen, Nicholas Lintzeris, Fiona Shand, Wayne D Hall, Bianca Hoban, Chyanne Kehler, Michael Farrell, Louisa Degenhardt, None, Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study BMC Pharmacology and Toxicology. ,vol. 15, pp. 17- 17 ,(2014) , 10.1186/2050-6511-15-17
Randy A. Sansone, Philip Whitecar, Michael W. Wiederman, The Prevalence of Childhood Trauma Among Those Seeking Buprenorphine Treatment Journal of Addictive Diseases. ,vol. 28, pp. 64- 67 ,(2009) , 10.1080/10550880802545101
Robert H. Dworkin, Dennis C. Turk, John T. Farrar, Jennifer A. Haythornthwaite, Mark P. Jensen, Nathaniel P. Katz, Robert D. Kerns, Gerold Stucki, Robert R. Allen, Nicholas Bellamy, Daniel B. Carr, Julie Chandler, Penney Cowan, Raymond Dionne, Bradley S. Galer, Sharon Hertz, Alejandro R. Jadad, Lynn D. Kramer, Donald C. Manning, Susan Martin, Cynthia G. McCormick, Michael P. McDermott, Patrick McGrath, Steve Quessy, Bob A. Rappaport, Wendye Robbins, James P. Robinson, Margaret Rothman, Mike A. Royal, Lee Simon, Joseph W. Stauffer, Wendy Stein, Jane Tollett, Joachim Wernicke, James Witter, Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. ,vol. 113, pp. 9- 19 ,(2003) , 10.1016/J.PAIN.2004.09.012